期刊
EUROPEAN JOURNAL OF PHARMACOLOGY
卷 588, 期 1, 页码 18-25出版社
ELSEVIER
DOI: 10.1016/j.ejphar.2008.03.058
关键词
Alzheimer's disease; amyloid-beta peptide (A beta); angiotensin-converting enzyme (ACE); catalytic domains of ACE; neprilysin (NEP)
Catabolic processes play a crucial role in the steady state of the amyloid-beta peptide (A beta). Neprilysin (NEP) and angiotensin-converting enzyme (ACE), two transmembranal enzymes with greatest importance in peptide pharmacology, are known to play a role in A beta catabolism. This paper focuses on the N-terminal part of A beta. This region contains the three amino acid residues that determine the differences between human (hA beta) and murine A beta (mA beta). Moreover, the N-terminal part of A beta contains the zinc-binding site of the molecule. Consequently, all hydrolytic attacks on this part of the Alzheimer peptide should be of exceptional interest. We investigated domain-selective forms of ACE in HPLC-monitored peptide degradation studies and used mass spectrometry for product analyses. We found that ACE-evoked a hydrolysis of the N-terminal part of m- and hA beta. The hA beta sequence hA beta (4-15) was found to be a better substrate for ACE compared to the corresponding murine form. Moreover, we localized the corresponding cleavage sites in the N-terminal part of A beta as well as in the full-length molecule and identified new sites of endopeptidolytic attack by ACE. Finally, we demonstrate that both catalytic domains of mACE have similar hydrolytic activity on the N-terminal part of A beta. Our results show that ACE besides its typical function as a dipeptidyl-carboxypeptidase has also unequivocal endopeptidolytic activities. (C) 2008 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据